A Business strategy development for a law firm in a period of economical recession.
Oleksiy Bezhevets, partner of Legal Alliance Company
The global economic recession has had a significant impact on the Ukrainian legal services industry, calling for a strategic change for the law companies working in Ukraine. The idea of this article is to describe the process of development of a law company's business strategy, specifically for the period of recession.
Theory prescribes that strategy formulation is the development of long-range plans for the effective management of environmental opportunities and threats, in light of corporate strengths and weaknesses. It includes defining the corporate mission, specifying achievable objectives, developing strategies, and setting policy guidelines. The following 5 steps of the strategic decision making process were proposed:
Let us take as an example a strategic research undertaken in a law company that provided answers to the main questions to be answered for a strategy development, precisely:
How can the company's current performance be evaluated?
The company's general underperformance and a gap between the strategy and the business environment was detected and described in numbers. It was proved that financial trends in the company were troublesome. It was argued that the company's current business strategy does not map to the business environment and does not provide for a sustainable competitive advantage in the period of economic recession. It was proved by the SWOT analysis that the company's response to the external and internal environmental factors is very poor (36% and 56.5% of the possible performance level respectively).
What environmental factors should be taken into account by the company in addressing the issue?
The environmental factors that should be taken into account by the company while defining the business strategy for the specified period were elaborated upon as the following: the market demands a fixed fee agreed in advance and hourly rates with a cap; competence in pharmaceutical law (one of the company's core practice); competitors, especially in pharmaceutical law and litigation; general reduction in expenses among clients; clients' financial problems; growing demand for services in litigation, taxation, bad assets collection, and intellectual property rights; and some others.
What strategic alternatives does the company have for the period of economic recession?
The analysis of the survey data has updated the list of the internal and external strategic factors that have an influence on the company before recession. The updated strategic environmental factors were organized into the categories of strengths and weaknesses, and opportunities and threats, to analyze how well the company responds to these specific factors in light of the perceived importance of these factors. The TOWS Matrix was generated to illustrate how the external opportunities and threats facing the company can be matched with the company's internal strengths and weaknesses to result in four sets of possible strategic alternatives, precisely:
Strengths and opportunities strategies
Weaknesses and opportunities strategies
Strengths and threats strategies
Weaknesses and threats strategies
What strategic alternative can be recommended to the company for the specified period?
The elaborated strategic alternatives, along with the market trends and the authoritative opinions explored by the undertaken research, have culminated in the following business strategy objectives recommended to the company for the period of economic recession:
What objectives in the financial, marketing, internal business process, and human resources and information technology fields can be set for the company?
According to the new strategic objectives elaborated for the company, the new objectives in the financial, marketing, internal business process, and human resources and information technology fields were set for the company.
27 January 2012
27 January 2012
23 January 2012
23 January 2012
17 January 2012
13 January 2012
Legal Alliance appealed to the AMCU in the interest of participants of the pharmaceutical market